Glucagon-like Peptide-1 Receptor in the Human Hypothalamus Is Associated with Body Mass Index and Colocalizes with the Anorexigenic Neuropeptide Nucleobindin-2/Nesfatin-1

Minireview: Peripheral Nesfatin-1 in Regulation of the Gut Activity—15 Years since the Discovery

(2022) Katarzyna Kras et al.   Animals

Nesfatin-1 ameliorates oxidative brain damage and memory impairment in rats induced with a single acute epileptic seizure

(2022) Sevil Arabacı Tamer et al.   LIFE SCIENCES

Nucleobindin-2/Nesfatin-1—A New Cancer Related Molecule?

(2021) Alicja M. Kmiecik et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Role of liraglutide in Alzheimer’s disease pathology

(2021) Maria Vargas-Soria et al.   Alzheimers Research & Therapy

GLP-1 Receptor Signaling in Astrocytes Regulates Fatty Acid Oxidation, Mitochondrial Integrity, and Function

(2020) Katharina Timper et al.   Cell Metabolism

A novel mouse model of glucagon‐like peptide‐1 receptor expression: a look at the brain

(2020) Devon L. Graham et al.   JOURNAL OF COMPARATIVE NEUROLOGY

Nucleobindin 2/nesfatin‐1 expression and colocalization with neuropeptide Y and cocaine‐ and amphetamine‐regulated transcript in the human brainstem

(2020) Aristea Psilopanagioti et al.   JOURNAL OF NEUROENDOCRINOLOGY

Nucleobindin-2/nesfatin-1 in the human hypothalamus is reduced in obese subjects and colocalizes with oxytocin, vasopressin, melanin-concentrating hormone, and cocaine- and amphetamine-regulated transcript

(2019) Aristea Psilopanagioti et al.   NEUROENDOCRINOLOGY

Weight loss variability with SGLT2 inhibitors and GLP‐1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities

(2019) Emily Brown et al.   Obesity Reviews

Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson’s Disease

(2019) Dong Dong et al.   Neuroscience Bulletin

Glucagon-like peptide 1 (GLP-1)

(2019) T.D. Müller et al.   Molecular Metabolism

Glucagon-like peptide 1 in health and disease

(2018) Andreas Andersen et al.   Nature Reviews Endocrinology

Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy

(2018) Eridan Rocha-Ferreira et al.   BRAIN

The Hypothalamic Preoptic Area and Body Weight Control

(2017) Sangho Yu et al.   NEUROENDOCRINOLOGY

GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial

(2016) Olivia M. Farr et al.   DIABETOLOGIA

Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients

(2016) Jennifer S. ten Kulve et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Nesfatin-1: functions and physiology of a novel regulatory peptide

(2016) Riccardo Dore et al.   JOURNAL OF ENDOCRINOLOGY

Activation of Nesfatin-1-Containing Neurones in the Hypothalamus and Brainstem by Peripheral Administration of Anorectic Hormones and Suppression of Feeding via Central Nesfatin-1 in Rats

(2016) R. Saito et al.   JOURNAL OF NEUROENDOCRINOLOGY

Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance

(2016) D. J. Reiner et al.   JOURNAL OF NEUROSCIENCE

Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders

(2016) M A Lebow et al.   MOLECULAR PSYCHIATRY

Lateral hypothalamic circuits for feeding and reward

(2016) Garret D Stuber et al.   NATURE NEUROSCIENCE

Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist

(2016) Kenichi Katsurada et al.   Journal of Diabetes Investigation

Expression and Distribution of Glucagon-Like Peptide-1 Receptor mRNA, Protein and Binding in the Male Nonhuman Primate (Macaca mulatta) Brain

(2015) Kristy M. Heppner et al.   ENDOCRINOLOGY

Dopamine D1 receptor activation regulates the expression of the estrogen synthesis gene aromatase B in radial glial cells

(2015) Lei Xing et al.   Frontiers in Neuroscience

Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain

(2015) Simon C. Cork et al.   Molecular Metabolism

Endogenous GLP-1 acts on paraventricular nucleus to suppress feeding: Projection from nucleus tractus solitarius and activation of corticotropin-releasing hormone, nesfatin-1 and oxytocin neurons

(2014) Kenichi Katsurada et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans

(2014) L. van Bloemendaal et al.   DIABETES

The effect of exogenous GLP-1 on food intake is lost in male truncally vagotomized subjects with pyloroplasty

(2013) Astrid Plamboeck et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model

(2013) P. Richards et al.   DIABETES

Role of orexin in modulating arousal, feeding, and motivation

(2013) Natsuko Tsujino et al.   Frontiers in Behavioral Neuroscience

Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders

(2012) Isidro Salcedo et al.   BRITISH JOURNAL OF PHARMACOLOGY

Quantitative Determination of Spatial Protein-Protein Correlations in Fluorescence Confocal Microscopy

(2010) Yong Wu et al.   BIOPHYSICAL JOURNAL

Nesfatin-1: a novel inhibitory regulator of food intake and body weight

(2010) A. Stengel et al.   Obesity Reviews